Increased Expression of CD44 Variants in Differentiated Thyroid Cancers
- 1 December 1996
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 87 (12) , 1245-1250
- https://doi.org/10.1111/j.1349-7006.1996.tb03139.x
Abstract
Expression of CD44 variants in thyroid tumors was analyzed by reverse transcription‐polymerase chain reaction (RT‐PCR) with a fluorescent image analyzer. Increased expression of CD44 variants compared with normal thyroid tissues was observed in most thyroid follicular tumors, especially in follicular carcinomas, poorly differentiated papillary carcinomas and some follicular adenomas. However, variants were hardly detectable in an anaplastic carcinoma. Analysis with restriction enzymes revealed that the major PCR product, consisting of variant bands, was derived from CD44E. Therefore, the expression of CD44E may be associated with the proliferation of differentiated thyroid cells.Keywords
This publication has 20 references indexed in Scilit:
- CD44 expression patterns in breast and colon tumors: A pcr‐based study of splice variantsInternational Journal of Cancer, 1995
- New CD44 splice variants associated with human breast cancersJournal of Cellular Physiology, 1995
- Preferential Expression of the Cell Adhesion Molecule CD44 in Papillary Thyroid CarcinomaExperimental and Molecular Pathology, 1994
- Duchenne/becker muscular dystrophy carrier detection using quantitative PCR and fluorescence‐based strategiesAmerican Journal of Medical Genetics, 1993
- CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagenSurgical Oncology, 1993
- [33] Polymerase chain reaction-based mRNA quantification using an internal standard: Analysis of oncogene expressionPublished by Elsevier ,1993
- Expression of the Hermes-1 (CD44) and ICAM-1 (CD54) Molecule on the Surface of Thyroid Cells from Patients with Graves' DiseaseThyroid®, 1993
- CD44 and its role in tumour progression and metastasisEuropean Journal Of Cancer, 1993
- Significance of CD44 gene products for cancer diagnosis and disease evaluationThe Lancet, 1992
- Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons.The Journal of cell biology, 1991